17-75846959-G-A
Variant names:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_012478.4(WBP2):c.681C>T(p.Ala227Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00601 in 1,614,114 control chromosomes in the GnomAD database, including 242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 106 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 136 hom. )
Consequence
WBP2
NM_012478.4 synonymous
NM_012478.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.785
Genes affected
WBP2 (HGNC:12738): (WW domain binding protein 2) The globular WW domain is composed of 38 to 40 semiconserved amino acids shared by proteins of diverse functions including structural, regulatory, and signaling proteins. The domain is involved in mediating protein-protein interactions through the binding of polyproline ligands. This gene encodes a WW domain binding protein that is a transcriptional coactivator of estrogen receptor alpha and progesterone receptor. Defects in this gene have been associated with hearing impairment. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 17-75846959-G-A is Benign according to our data. Variant chr17-75846959-G-A is described in ClinVar as [Benign]. Clinvar id is 1243088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.785 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.065 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WBP2 | NM_012478.4 | c.681C>T | p.Ala227Ala | synonymous_variant | Exon 7 of 8 | ENST00000254806.8 | NP_036610.2 | |
WBP2 | NM_001348170.1 | c.681C>T | p.Ala227Ala | synonymous_variant | Exon 8 of 9 | NP_001335099.1 | ||
WBP2 | NM_001330499.2 | c.546C>T | p.Ala182Ala | synonymous_variant | Exon 6 of 7 | NP_001317428.1 | ||
WBP2 | XM_047435712.1 | c.615C>T | p.Ala205Ala | synonymous_variant | Exon 7 of 8 | XP_047291668.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0222 AC: 3383AN: 152154Hom.: 106 Cov.: 32
GnomAD3 genomes
AF:
AC:
3383
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0129 AC: 3231AN: 251138Hom.: 76 AF XY: 0.0109 AC XY: 1479AN XY: 135826
GnomAD3 exomes
AF:
AC:
3231
AN:
251138
Hom.:
AF XY:
AC XY:
1479
AN XY:
135826
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00431 AC: 6307AN: 1461842Hom.: 136 Cov.: 32 AF XY: 0.00429 AC XY: 3122AN XY: 727224
GnomAD4 exome
AF:
AC:
6307
AN:
1461842
Hom.:
Cov.:
32
AF XY:
AC XY:
3122
AN XY:
727224
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0223 AC: 3389AN: 152272Hom.: 106 Cov.: 32 AF XY: 0.0219 AC XY: 1631AN XY: 74448
GnomAD4 genome
AF:
AC:
3389
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
1631
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
79
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 05, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at